Semi-Annual Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7553053

Concept 2023-03-01 to
2023-05-31
2022-03-01 to
2022-05-31
Semi-annual statement of income
Statement of income
Net sales
32,096,000,000 JPY
26,393,000,000 JPY
Cost of sales
13,378,000,000 JPY
11,647,000,000 JPY
Ordinary profit (loss)
5,713,000,000 JPY
2,298,000,000 JPY
Gross profit (loss)
18,718,000,000 JPY
14,745,000,000 JPY
Extraordinary income
JPY
141,000,000 JPY
Selling, general and administrative expenses
14,356,000,000 JPY
14,225,000,000 JPY
Extraordinary losses
0 JPY
41,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
4,361,000,000 JPY
519,000,000 JPY
Profit (loss) before income taxes
5,712,000,000 JPY
2,398,000,000 JPY
Non-operating income
1,413,000,000 JPY
1,929,000,000 JPY
Non-operating income
Interest income
470,000,000 JPY
52,000,000 JPY
Dividend income
90,000,000 JPY
83,000,000 JPY
Non-operating expenses
61,000,000 JPY
150,000,000 JPY
Income taxes
1,533,000,000 JPY
657,000,000 JPY
Profit (loss)
4,179,000,000 JPY
1,740,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
0 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.